Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics

OBJECTIVE: To determine the safety and pharmacokinetics of erythropoietin (Epo) given in conjunction with hypothermia for hypoxic-ischemic encephalopathy (HIE). We hypothesized that high dose Epo would produce plasma concentrations that are neuroprotective in animal studies (ie, maximum concentratio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wu, Yvonne W., Bauer, Larry A., Ballard, Roberta A., Ferriero, Donna M., Glidden, David V., Mayock, Dennis E., Chang, Taeun, Durand, David J., Song, Dongli, Bonifacio, Sonia L., Gonzalez, Fernando F., Glass, Hannah C., Juul, Sandra E.
Format: Artigo
Idioma:Inglês
Publicat: American Academy of Pediatrics 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457622/
https://ncbi.nlm.nih.gov/pubmed/23008465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2012-0498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars